Dyax Corporation CEO Discusses Q2 2012 Results - Earnings Call Transcript

Dyax Corporation (DYAX)

Q2 2012 Earnings Call

July 19, 2012, 5:00 p.m. ET

Executives

Gustav Christiansen – President, CEO

Rick Berard – VP Commercial

Burt Adelman – Chief Medical Officer

Ivana Magovčević-Liebisch - EVP, Corporate Development and General Counsel

George Miguasky - EVP, CFO.

Analysts

Joseph Schwartz – Leerink Swann LLC

Phil Nadeau - Cowen and Company

Serge Boulanger – Needham and Company

Presentation

Operator

Good afternoon, and welcome ladies and gentlemen to the Dyax Corporation Second Quarter 2012 financial earnings call. At this time, I would like to inform you that this conference call is being recorded, and that the participants are in a listen-only mode. (operator instructions).

Before turning this call over to Gustav Christiansen, President and Chief Executive Officer of Dyax, the company will now read their Safe Harbor Statement.

Unidentified Company Representative

This afternoon, Dyax issued a press release concerning second quarter 2012 financial results. Dyax would like to remind everyone that statements made today reflect current expectations, estimates and projections about products, programs, collaborations, strategies and financial performance, and are forward-looking statements. These statements, including those related to Dyax’s FDA-approved product KALBITOR, are subject to risks and uncertainties that could cause actual events and results to differ materially. Important information concerning these risks and uncertainties is contained in Dyax’s press release today, and described or referred to in its most recent form 10-K and other periodic reports filed with the SEC, and are also available on the company’s website at www.dyax.com. I will now turn the call over to Gustav Christiansen, President and CEO of Dyax. Gustav?

Gustav Christiansen

If you liked this article you might like

Shire to Acquire Biopharma Company Baxalta in $32B Deal

The Nominees for Best Biopharma CEO of 2015 Are...

3 Drugs Stocks Moving The Industry Upward

Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours

OPEC Begins Meeting Today, Saudis May Cut Oil Production